Upcoming AAN conference to feature Ocrevus studies sponsored by Genentech on: April 16, 2018, 02:16:56 pm #1 It looks as if Genentech will be presenting quite a number of papers showing the efficacy and safety of Ocrevus at the annual AAN conference that will take place this month. There are a number of other new drugs on the list of presentations too. Access Denied businesswire.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
